ProfileGDS4718 / 213068_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 80% 94% 49% 80% 21% 41% 72% 90% 72% 67% 72% 35% 29% 41% 60% 85% 33% 50% 53% 80% 81% 62% 87% 69% 40% 78% 55% 74% 39% 29% 57% 70% 26% 51% 36% 13% 90% 51% 97% 66% 21% 57% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9775258
GSM549102patient 115, normal, homogenized [OPG study]7.7539580
GSM549104patient 119, normal, homogenized [OPG study]10.071994
GSM549108patient 138, normal, homogenized [OPG study]5.4812749
GSM549119patient 077, normal, homogenized [OPG study]7.8408380
GSM549133patient 032, cancer, homogenized [OPG study]4.148921
GSM549139patient 042, cancer, homogenized [OPG study]5.0463541
GSM549099patient 107, normal, homogenized [OPG study]6.9777572
GSM549109patient 139, normal, homogenized [OPG study]9.1491690
GSM549110patient 046, normal, homogenized [OPG study]6.9864472
GSM549114patient 063, normal, homogenized [OPG study]6.6109867
GSM549122patient 082, normal, homogenized [OPG study]7.0747772
GSM549134patient 033, cancer, homogenized [OPG study]4.7564735
GSM549136patient 036, cancer, homogenized [OPG study]4.4514829
GSM549140patient 044, cancer, homogenized [OPG study]5.0057641
GSM549111patient 047, normal, homogenized [OPG study]6.1260560
GSM549113patient 057, normal, homogenized [OPG study]8.6818885
GSM549132patient 031, cancer, homogenized [OPG study]4.6683533
GSM549137patient 038, cancer, homogenized [OPG study]5.490650
GSM549142patient 047, cancer, homogenized [OPG study]5.7902953
GSM549100patient 110, normal, homogenized [OPG study]7.7673880
GSM549107patient 135, normal, homogenized [OPG study]8.0173381
GSM549115patient 068, normal, homogenized [OPG study]6.2713862
GSM549116patient 072, normal, homogenized [OPG study]8.7801587
GSM549120patient 078, normal, homogenized [OPG study]6.7758969
GSM549131patient 030, cancer, homogenized [OPG study]4.9173840
GSM549118patient 074, normal, homogenized [OPG study]7.6429378
GSM549129patient 027, cancer, homogenized [OPG study]5.8483355
GSM549123patient 088, normal, homogenized [OPG study]7.2908674
GSM549124patient 006, cancer, homogenized [OPG study]4.9698139
GSM549126patient 015, cancer, homogenized [OPG study]4.4818329
GSM549128patient 025, cancer, homogenized [OPG study]5.9680157
GSM549103patient 117, normal, homogenized [OPG study]6.8206170
GSM549117patient 073, normal, homogenized [OPG study]4.3638726
GSM549138patient 041, cancer, homogenized [OPG study]5.5476251
GSM549141patient 045, cancer, homogenized [OPG study]4.723636
GSM549130patient 028, cancer, homogenized [OPG study]3.8982313
GSM549101patient 111, normal, homogenized [OPG study]9.0797690
GSM549105patient 128, normal, homogenized [OPG study]5.5777751
GSM549106patient 134, normal, homogenized [OPG study]10.872597
GSM549112patient 048, normal, homogenized [OPG study]6.5725566
GSM549125patient 011, cancer, homogenized [OPG study]4.1813521
GSM549127patient 024, cancer, homogenized [OPG study]5.943757
GSM549135patient 035, cancer, homogenized [OPG study]4.0771419